Physician profile
Brian Kwon
NPI 1306848890
$1,911,144.73
in general payments reported to CMS, 2019-2025
33 companies · $373K in 2025
The $373K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63K · 2020: $24K · 2021: $155K · 2022: $438K · 2023: $578K · 2024: $280K · 2025: $373K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.1M · Consulting Fee: $79K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Travel and Lodging: $22K · Acquisitions: $9,791 · Food and Beverage: $8,103 · Education: $30.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,089,615.24 |
| Consulting Fee | $78,550.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,560.00 |
| Travel and Lodging | $22,349.02 |
| Acquisitions | $9,790.59 |
| Food and Beverage | $8,102.58 |
| Education | $30.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $1,077,036.11 | 2019-2023 | Alif, Modulus, Pulse |
| Globus Medical, INC. | $557,696.14 | 2024-2025 | Modulus, Modulus, Elsa |
| Depuy Synthes Products, INC. | $137,275.10 | 2022-2023 | Fibulink |
| Medtronic, INC. | $53,140.41 | 2021-2025 | Unid_pass, Mazor X System, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Amplify Surgical, INC. | $24,490.68 | 2022-2025 | Dual-X Portal, Dual-X, Dualx and Dualportal |
| Prosidyan, INC | $12,500.00 | 2019 | |
| Tyber Medical, LLC | $10,855.00 | 2025 | X02-04 Llif Disc Prep |
| Surgalign Spine Technologies, INC. | $10,772.58 | 2022 | |
| Cerapedics INC. | $8,036.38 | 2023-2025 | I-Factor Peptide Enhanced Bone Graft |
| Alphatec Spine, INC | $6,874.23 | 2019-2025 | Other - Miscellaneous, Invictus Mis, Solus Alif |
| Evolution Spine, LLC | $4,310.15 | 2024 | Integrated Alif System |
| Stryker Corporation | $2,588.31 | 2019-2025 | Everest Spinal System |
| Kairos Surgical INC | $2,175.82 | 2023-2024 | |
| Arthrex, INC. | $681.52 | 2023-2024 | |
| Curiteva, INC. | $416.19 | 2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuros Biosciences USA, INC | $412.95 | 2019-2024 | Magnetos |
| Bioventus LLC | $387.06 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Trackx Technology, INC. | $316.86 | 2025 | |
| Spineology INC. | $290.20 | 2019-2024 | Optimesh Expandable Interbody Fusion System |
| Si-Bone, INC. | $245.10 | 2019-2022 | |
| Orthofix Medical, INC. | $157.95 | 2021-2023 | |
| Seaspine Orthopedics Corporation | $118.22 | 2022 | |
| Medical Device Business Services, INC. | $102.95 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $80.26 | 2024-2025 | |
| Integra Lifesciences Corporation | $27.27 | 2024 | Instruments-Orthopedic, Integra Duo, Integra |
| Endo USA, INC. | $26.40 | 2025 | Xiaflex |
| Abbott Laboratories | $25.22 | 2024 | Proclaim |
| Baudax Bio INC. | $24.96 | 2022 | |
| Siemens Medical Solutions USA, INC. | $20.33 | 2025 | Cios Flow |
| Djo, LLC | $15.79 | 2024 | Cmf |
| Spinal Simplicity, LLC | $15.68 | 2024 | Ha Minuteman G3-R |
| Integrity Implants INC. Dba Accelus | $14.97 | 2024 | |
| Depuy Synthes Sales INC. | $13.94 | 2025 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,462,500.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.